Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 4Recruiting 3Terminated 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Neoplasms 1Motor Activity 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × beta-Glucans × Clear all
NCT07305259 2025-12-26

REACT

Florida State University

Phase EARLY_PHASE1 Recruiting
60 enrolled

Motor Activity, Neoplasms

NCT04513028 2025-10-30

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma

University of Louisville

Phase NA Recruiting
30 enrolled
Dermatologic

Melanoma

NCT00682032 2025-01-10

The Effect of Beta-glucan in Non-Small Cell Lung Cancer

University of Louisville

Phase NA Recruiting
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡